- Home
- HUMA vs LEO Comparison
HUMA vs LEO Comparison
Compare HUMA & LEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- LEO
- Stock Information
- Founded
- HUMA 2004
- LEO 1987
- Country
- HUMA United States
- LEO United States
- Employees
- HUMA N/A
- LEO N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- LEO Trusts Except Educational Religious and Charitable
- Sector
- HUMA Health Care
- LEO Finance
- Exchange
- HUMA Nasdaq
- LEO Nasdaq
- Market Cap
- HUMA 356.8M
- LEO 362.5M
- IPO Year
- HUMA N/A
- LEO N/A
- Fundamental
- Price
- HUMA $2.48
- LEO $5.89
- Analyst Decision
- HUMA Strong Buy
- LEO
- Analyst Count
- HUMA 7
- LEO 0
- Target Price
- HUMA $13.00
- LEO N/A
- AVG Volume (30 Days)
- HUMA 4.3M
- LEO 200.2K
- Earning Date
- HUMA 08-11-2025
- LEO 01-01-0001
- Dividend Yield
- HUMA N/A
- LEO 4.01%
- EPS Growth
- HUMA N/A
- LEO N/A
- EPS
- HUMA N/A
- LEO 0.04
- Revenue
- HUMA $517,000.00
- LEO N/A
- Revenue This Year
- HUMA N/A
- LEO N/A
- Revenue Next Year
- HUMA $936.09
- LEO N/A
- P/E Ratio
- HUMA N/A
- LEO $152.00
- Revenue Growth
- HUMA N/A
- LEO N/A
- 52 Week Low
- HUMA $1.15
- LEO $4.98
- 52 Week High
- HUMA $8.24
- LEO $6.50
- Technical
- Relative Strength Index (RSI)
- HUMA 53.95
- LEO 56.32
- Support Level
- HUMA $2.14
- LEO $5.78
- Resistance Level
- HUMA $2.39
- LEO $5.81
- Average True Range (ATR)
- HUMA 0.21
- LEO 0.05
- MACD
- HUMA -0.01
- LEO 0.01
- Stochastic Oscillator
- HUMA 48.57
- LEO 75.00
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About LEO BNY Mellon Strategic Municipals Inc.
BNY Mellon Strategic Municipals, Inc. is a diversified closed-end management investment company. The fund's investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. Its products are Equity and Fixed Income Mutual Funds, Retail Money Market Funds, Government/Treasury Money Market Funds, Institutional Money Market Funds, and others. BNY Mellon and its affiliates, including BNYM Investment Adviser, INA and others involved in the management, sales, investment activities, business operations or distribution of the Fund, are engaged in businesses and have interests other than that of managing the Fund.